<VariationArchive VariationID="967596" VariationName="NM_001122630.2(CDKN1C):c.417_420del (p.Val140fs)" VariationType="Deletion" Accession="VCV000967596" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="956457" VariationID="967596">
      <GeneList>
        <Gene Symbol="CDKN1C" FullName="cyclin dependent kinase inhibitor 1C" GeneID="1028" HGNC_ID="HGNC:1786" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2883218" stop="2885775" display_start="2883218" display_stop="2885775" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NT_187585.1" start="115397" stop="117985" display_start="115397" display_stop="117985" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2904447" stop="2906994" display_start="2904447" display_stop="2906994" Strand="-" />
          </Location>
          <OMIM>600856</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN1C">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN1C">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001122630.2(CDKN1C):c.417_420del (p.Val140fs)</Name>
      <CanonicalSPDI>NC_000011.10:2885036:GACTG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2885037" stop="2885040" display_start="2885037" display_stop="2885040" variantLength="4" positionVCF="2885036" referenceAlleleVCF="GGACT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2906267" stop="2906270" display_start="2906267" display_stop="2906270" variantLength="4" positionVCF="2906266" referenceAlleleVCF="GGACT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>V140fs</ProteinChange>
      <ProteinChange>V151fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_533" sequenceAccession="LRG_533">
            <Expression>LRG_533:g.5726_5729del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_533t1" sequenceAccession="LRG_533t1">
            <Expression>LRG_533t1:c.450_453del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_533p1" sequenceAccession="LRG_533p1" change="p.Val151fs">
            <Expression>LRG_533p1:p.Val151fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.2885038_2885041del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.2885038_2885041del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.2906268_2906271del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.2906268_2906271del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008022.1" sequenceAccession="NG_008022" sequenceVersion="1" change="g.5726_5729del">
            <Expression>NG_008022.1:g.5726_5729del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000076.2" sequenceAccession="NM_000076" sequenceVersion="2" change="c.450_453del">
            <Expression>NM_000076.2:c.450_453del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000067.1" sequenceAccession="NP_000067" sequenceVersion="1" change="p.Val151fs">
            <Expression>NP_000067.1:p.Val151fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122630.2" sequenceAccession="NM_001122630" sequenceVersion="2" change="c.417_420del" MANESelect="true">
            <Expression>NM_001122630.2:c.417_420del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116102.1" sequenceAccession="NP_001116102" sequenceVersion="1" change="p.Val140fs">
            <Expression>NP_001116102.1:p.Val140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122631.2" sequenceAccession="NM_001122631" sequenceVersion="2" change="c.417_420del">
            <Expression>NM_001122631.2:c.417_420del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116103.1" sequenceAccession="NP_001116103" sequenceVersion="1" change="p.Val140fs">
            <Expression>NP_001116103.1:p.Val140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362474.2" sequenceAccession="NM_001362474" sequenceVersion="2" change="c.450_453del">
            <Expression>NM_001362474.2:c.450_453del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001349403.1" sequenceAccession="NP_001349403" sequenceVersion="1" change="p.Val151fs">
            <Expression>NP_001349403.1:p.Val151fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362475.2" sequenceAccession="NM_001362475" sequenceVersion="2" change="c.255+162_255+165del">
            <Expression>NM_001362475.2:c.255+162_255+165del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1848953740" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001122630.2(CDKN1C):c.417_420del (p.Val140fs) AND Beckwith-Wiedemann syndrome" Accession="RCV001242553" Version="5">
        <ClassifiedConditionList TraitSetID="1134">
          <ClassifiedCondition DB="MedGen" ID="C0004903">Beckwith-Wiedemann syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-10-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-10-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20503313</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1134" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="589" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beckwith-Wiedemann syndrome</ElementValue>
                <XRef ID="Beckwith-Wiedemann+Syndrome/774" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007534" DB="MONDO" />
                <XRef ID="81780002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Exomphalos macroglossia gigantism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EMG Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BWS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WBS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3343" />
                <XRef ID="3343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits. BWS is considered a clinical spectrum, in which affected individuals may have many of these features or may have only one or two clinical features. Early death may occur from complications of prematurity, hypoglycemia, cardiomyopathy, macroglossia, or tumors. However, the previously reported mortality of 20% is likely an overestimate given better recognition of the disorder along with enhanced treatment options. Macroglossia and macrosomia are generally present at birth but may have postnatal onset. Growth rate slows around age seven to eight years. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues.</Attribute>
                <XRef ID="NBK1394" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301568</ID>
                <ID Source="BookShelf">NBK1394</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3111049</ID>
              </Citation>
              <Citation Type="general" Abbrev="Italian BWS Association, 2016">
                <ID Source="PubMed">26592461</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32296163</ID>
              </Citation>
              <XRef ID="116" DB="Orphanet" />
              <XRef ID="C0004903" DB="MedGen" />
              <XRef ID="MONDO:0007534" DB="MONDO" />
              <XRef Type="MIM" ID="130650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2750738" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="8337226|MedGen:C0004903" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001415648" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20503313</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val151Argfs*120) in the CDKN1C gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CDKN1C are known to be pathogenic (PMID: 20503313). This variant has not been reported in the literature in individuals with CDKN1C-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN1C" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2906267_2906270del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0004903" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2750738" TraitType="Disease" MappingType="XRef" MappingValue="C0004903" MappingRef="MedGen">
        <MedGen CUI="C0004903" Name="Beckwith-Wiedemann syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

